Theratechnologies (TSE:TH) Stock Falls 4.9% – Should You Sell?

Theratechnologies Inc. (TSE:TH – Get Free Report)’s share price traded down 4.9% during trading on Friday. The stock traded as low as C$4.36 and last traded at C$4.47. Approximately 35,472 shares traded hands during trading, a decline of 53% from the average daily volume of 75,081 shares. The stock had previously closed at C$4.70.

Theratechnologies Price Performance

The firm has a fifty day moving average of C$4.47 and a 200 day moving average of C$4.47. The company has a market capitalization of C$205.53 million, a P/E ratio of -23.53, a P/E/G ratio of -8.50 and a beta of 0.26. The company has a current ratio of 1.19, a quick ratio of 0.64 and a debt-to-equity ratio of -180.46.

About Theratechnologies

(Get Free Report)

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

See Also

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.